| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 462-TR-010/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 462-TEC-010/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 6449-TEC-010/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-56512SS | |||
| Azide and BSA Free | NB100-56593SS | |||
| Azide and BSA Free | NB100-56593 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 390-TN-010/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 2166-TS-025/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50337-0.025ml | |||
![N/A TRANCE/TNFSF11/RANK L [HRP]](http://images.novusbio.com/fullsize2/DATA_TRANCE_MTR00_ELISA_1043.jpg "N/A TRANCE/TNFSF11/RANK L [HRP]")
![N/A TRANCE/TNFSF11/RANK L [HRP]](http://images.novusbio.com/fullsize2/TRANCE_MTR00_ELISA_330.jpg)
![Immunohistochemistry: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - MQDL detects EMT biomarkers in clinical prostate cancer. EMT biomarkers (EpCAM, N-Cad, and RANKL)were detected in a clinical primary prostate cancer specimen (Gleason score 6; 3+3) with documented bone metastasis. M denotes cells that completed EMT and E/M indicates cells undergoing partial EMT. 400x. Image collected and cropped by CiteAb from the following publication (//journals.plos.org/plosone/article?id=10.1371/journal.pone.0028670) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-12A668-Immunohistochemistry-NB100-56512-img0019.jpg "Immunohistochemistry: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - MQDL detects EMT biomarkers in clinical prostate cancer. EMT biomarkers (EpCAM, N-Cad, and RANKL)were detected in a clinical primary prostate cancer specimen (Gleason score 6; 3+3) with documented bone metastasis. M denotes cells that completed EMT and E/M indicates cells undergoing partial EMT. 400x. Image collected and cropped by CiteAb from the following publication (//journals.plos.org/plosone/article?id=10.1371/journal.pone.0028670) licensed under a CC-BY license."){kind=icon}
![Western Blot: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - Analysis using Azide Free version of NB100-56512. Human lymph node lysate (35ug per lane, RIPA buffer). Band detected at ~35kDa and ~28kDa. (Expected MW of 35.5kDa according to NP_003692.1 and of 27.7kDa according to NP_143026.1)](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-12A668-Western-Blot-NB100-56512-img0016.jpg){kind=icon}
![Immunocytochemistry/Immunofluorescence: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - TRANCE was detected in immersion fixed mouse splenocytes using anti-human/mouse/rat mouse monoclonal antibody (Catalog # NB100-56512) for 1 hour at room temperature. Cells were stained using NL557 (red) fluorescent anti-mouse secondary antibodies (Catalog # NL007) and counterstained with DAPI (blue).](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-12A668-Immunocytochemistry-Immunofluorescence-NB100-56512-img0018.jpg){kind=icon}
![Immunohistochemistry: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - MQDL detects EMT biomarkers in clinical bone tissue specimens. A representative specimen of human prostate cancer bone metastasis co-expressed high levels of epithelial EpCAM, and mesenchymal RANKL and vimentin proteins. 400x. Image collected and cropped by CiteAb from the following publication (//journals.plos.org/plosone/article?id=10.1371/journal.pone.0028670) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-12A668-Immunohistochemistry-NB100-56512-img0020.jpg){kind=icon}
![Western Blot: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - Analysis of transfected cell lysate was probed with TRANCE/TNFSF11/RANK L antibody.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-12A668-Western-Blot-NB100-56512-img0013.jpg){kind=icon}
![Immunohistochemistry-Paraffin: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - Analysis using Azide Free version of NB100-56512. FFPE human liver stained with TRANCE/TNFSF11/RANK L antibody, peroxidase-conjugate and DAB chromogen. A 2 hr incubation at RT was used.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-12A668-Immunohistochemistry-Paraffin-NB100-56512-img0014.jpg){kind=icon}
![Immunohistochemistry-Paraffin: TRANCE/TNFSF11/RANK L Antibody (12A668) [NB100-56512] - Analysis using Azide Free version of NB100-56512. FFPE human lymph node probed with TRANCE/TNFSF11/RANK L antibody.](http://images.novusbio.com/fullsize/TRANCE-TNFSF11-RANK-L-Antibody-12A668-Immunohistochemistry-Paraffin-NB100-56512-img0015.jpg){kind=icon}
![N/A TRANCE/TNFSF11/RANK L [Biotin]](http://images.novusbio.com/fullsize2/DATA_TRANCE_DY626_ELISA_2158.jpg "N/A TRANCE/TNFSF11/RANK L [Biotin]")
![Western Blot: GITR/TNFRSF18 Antibody (T9P4G4/D7) [NBP2-50337]](http://images.novusbio.com/fullsize/GITR-TNFRSF18-Antibody-T9P4G4-D7-Western-Blot-NBP2-50337-img0001.jpg "Western Blot: GITR/TNFRSF18 Antibody (T9P4G4/D7) [NBP2-50337]")
![Immunohistochemistry: GITR/TNFRSF18 Antibody (T9P4G4/D7) [NBP2-50337]](http://images.novusbio.com/fullsize/GITR-TNFRSF18-Antibody-T9P4G4-D7-Immunohistochemistry-NBP2-50337-img0002.jpg)
![Immunohistochemistry: GITR/TNFRSF18 Antibody (T9P4G4/D7) [NBP2-50337] - Staining of GITR in a normal lymph node tissue cross section. Positive cytoplasmic/membranous immunostaining is observed in agreement with the literature.](http://images.novusbio.com/fullsize/GITR-TNFRSF18-Antibody-T9P4G4-D7-Immunohistochemistry-NBP2-50337-img0003.jpg)